ESR1 c.1610A>T ;(p.Y537F)

Variant ID: 6-152419923-A-T

NM_000125.3(ESR1):c.1610A>T;(p.Y537F)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer.

Frontiers In Endocrinology
Tecalco-Cruz, Angeles C AC; Macías-Silva, Marina M; Ramírez-Jarquín, Josué Orlando JO; Ramírez-Jarquín, Uri Nimrod UN
Publication Date: 2022

Variant appearance in text: ESR1: Y537F
PubMed Link: 35498431
Variant Present in the following documents:
  • Main text
  • fendo-13-867448.pdf
View BVdb publication page



Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.

Npj Breast Cancer
Shishido, Stephanie N SN; Masson, Rahul R; Xu, Liya L; Welter, Lisa L; Prabakar, Rishvanth Kaliappan RK; D' Souza, Anishka A; Spicer, Darcy D; Kang, Irene I; Jayachandran, Priya P; Hicks, James J; Lu, Janice J; Kuhn, Peter P
Publication Date: 2022-02-18

Variant appearance in text: ESR1: Y537F
PubMed Link: 35181666
Variant Present in the following documents:
  • 41523_2022_390_MOESM1_ESM.pdf
View BVdb publication page



Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability.

Cells
Jeffreys, Sarah A SA; Powter, Branka B; Balakrishnar, Bavanthi B; Mok, Kelly K; Soon, Patsy P; Franken, André A; Neubauer, Hans H; de Souza, Paul P; Becker, Therese M TM
Publication Date: 2020-09-11

Variant appearance in text: ESR1: Y537F
PubMed Link: 32932819
Variant Present in the following documents:
  • Main text
  • cells-09-02077.pdf
View BVdb publication page